Trial Profile
Fondaparinux Compared With Heparin to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary) ; Heparin
- Indications Thromboembolism; Vascular graft occlusion
- Focus Therapeutic Use
- Acronyms Fonda CABG
- 23 Jul 2007 New trial record.